These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1541067)

  • 1. Anti-platelet therapy in diabetic and non-diabetic progressive renal failure.
    Gordge MP; Rylance PB; Neild GH
    Clin Nephrol; 1992 Jan; 37(1):53-5. PubMed ID: 1541067
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
    Hopper AH; Tindall H; Davies JA
    Nephrol Dial Transplant; 1989; 4(2):140-3. PubMed ID: 2496357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
    Viecelli AK; Pascoe E; Polkinghorne KR; Hawley C; Paul-Brent PA; Badve SV; Cass A; Heritier S; Kerr PG; Mori TA; Robertson A; Seong HL; Irish AB;
    BMC Nephrol; 2015 Jun; 16():89. PubMed ID: 26116581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary protein restriction versus fish oil supplementation in the chronic remnant nephron model.
    Clark WF; Parbtani A; Philbrick DJ; Spanner E; Huff MW; Holub BJ
    Clin Nephrol; 1993 Jun; 39(6):295-304. PubMed ID: 8334756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy.
    Khajehdehi P; Roozbeh J; Mostafavi H
    Scand J Urol Nephrol; 2002; 36(2):145-8. PubMed ID: 12028688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U; Ong-Ajyooth L; Parichatikanond P; Ong-Ajyooth S; Liammongkolkul S; Kanyog S
    J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of treating glomerulonephritis with omega 3 fatty acids for selected parameters of hemostasis, blood platelet function and lipid metabolism].
    Małyszko JS; Małyszko J; Pawlak K; Myśliwiec M
    Przegl Lek; 1996; 53(8):600-3. PubMed ID: 8999460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy.
    Maachi K; Berthoux P; Burgard G; Alamartine E; Berthoux F
    Transplant Proc; 1995 Feb; 27(1):846-9. PubMed ID: 7879202
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of omega-3 fatty acid supplementation to plasma lipid peroxidation in predialysis patients with hypertriglyceridaemia.
    Richard MJ; Sirajeddine MK; Cordonnier D; Tricot F; Foulon T; Mouneimne A; Maurizi J
    Eur J Med; 1993 Jan; 2(1):15-8. PubMed ID: 8257999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive cardiology: what is the value of antiplatelet agents and fish oils?
    Lavie CJ; Squires RW; Gau GT
    South Med J; 1988 Sep; 81(9):1145-50. PubMed ID: 3047882
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
    Barnas U; Mayer G
    Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study.
    Aslan A; Triadafilopoulos G
    Am J Gastroenterol; 1992 Apr; 87(4):432-7. PubMed ID: 1553930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-inhibitor treatment of diabetic nephropathy: a 10-year prospective study.
    Donadio JV; Ilstrup DM; Holley KE; Romero JC
    Mayo Clin Proc; 1988 Jan; 63(1):3-15. PubMed ID: 3336239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
    Pisoni R; Faraone R; Ruggenent P; Remuzzi G
    J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of omega-3 fatty acids in psychiatry.
    McNamara RK
    Prostaglandins Leukot Essent Fatty Acids; 2006; 75(4-5):223-5. PubMed ID: 16930969
    [No Abstract]   [Full Text] [Related]  

  • 19. Marine oil capsule therapy for the treatment of hyperlipidemia.
    Davidson MH; Burns JH; Subbaiah PV; Conn ME; Drennan KB
    Arch Intern Med; 1991 Sep; 151(9):1732-40. PubMed ID: 1888238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of prolonged treatment with gliclazide on the course of proteinuria and renal function in diabetic nephropathy].
    Lagrue G; Kazandjian M; Gumpelson A; Riveline B
    Therapie; 1978; 33(5):629-37. PubMed ID: 741422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.